SlideShare a Scribd company logo
Overview of Peritoneal DialysisOverview of Peritoneal Dialysis
Piti Niyomsirivanich, MD.
Cardiology Fellowship of Maharat Nakhon Ratchasima Hospital
Peritoneal DialysisPeritoneal Dialysis
water
Urea/Cr
E’lyte
Urea/Cr
E’lyte
Ultrafiltration
Diffusion
plasma dialysate
Anatomy & PhysiologyAnatomy & Physiology
• 3 Pore Model
•Ultra-small or transcellular pores (0.4-0.6 nm.)
• Exist in small numbers and constitute 1-2 % of all pores
•Transport water only (sieving) :aquaporin-1(water channel)
Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005
Free water
•Small pores (4.0-6.0 nm.)
• Exist in large numbers and constitute 95% of all pores
•transport small solutes and water: interendothelial cleft
Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005
Small solute
e.g. Na ,K , Cr
•Large pores (20-24 nm)
•Exist in small numbers and constitute < 3% of all pores
•Transport macromolecules and anatomically large clefts
between endothelial cells : convection
Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005
albumin
Distributive Model
• Ultrafiltration
– Oncotic pressure gradient
– Hydrostatic pressure gradient
• Diffusion
– The concentration gradiant
– Effective peritoneal surface area
– Intrinsic peritoneal membrane resistance
– Molecular weight of the solute
• Fluid Reabsorption
– Occurs via the lymphatics  constant rate 1 ml/min
Sodium concentration in dialysate as a function of dwell time t.
Stachowska-Pietka J et al. Am J Physiol Renal Physiol
2012;302:F1331-F1341
©2012 by American Physiological Society
Intraperitoneal volume of dialysate as a function of dwell time t.
Stachowska-Pietka J et al. Am J Physiol Renal Physiol
2012;302:F1331-F1341
©2012 by American Physiological Society
Peritoneal Equilibration TestPeritoneal Equilibration Test
• PET : การทดสอบประสิทธิภาพของเยื่อบุช่อง
ท้องในการยอมให้สารผ่าน โดยเปรียบ
เทียบความเข้มข้นของสาร ณ เวลาหนึ่ง
• Concept :
การดึงของเสียการดึงของเสีย
: Bun, Cr, uremic toxin, K, P, Na
: สัดส่วนความเข้มข้นของสารนั้น ในนำ้ายาที่
ปล่อยออก : Dสารนั้น
ต่อความเข้มข้นของสารนั้น ในเลือด : Pสาร
นั้น
Peritoneal Equilibration TestPeritoneal Equilibration Test
> 0.81
< 0.5
ดูเรื่องการดึงนำ้า (UF) ดูเรื่องการแพร่ของ solute
PET
High Transporter Low Transporter
Less UF More UF
High Solute Transport Low Solute Transport
PD Technique & PrescriptionPD Technique & Prescription
Peritoneal Equilibration TestPeritoneal Equilibration Test
PET Prescription
High
Transporter
Short dwell time
Increase cycle
High Average NIPD/CAPD
Low Average High dose CAPD/CCPD
Low High dose CCPD+RRF
Switch to HD without RRF
PD SolutionPD Solution
• PDF Conc. : 1.5 % , 2.5%, 4.25% Dextrose
• Electrolyte
– Na (132 mEq/L) / Mg (0.5) / Cl (96)
– NaCl 538 mg/dL Sodium-lactate 448 mg/dL
CaCl 25.7mg/dL MgCl 5.08 mg/dL
– Lactate (40)  Bicarbonate
• pH : 5.2 (4-6.5)
• Osmole : 346
• New Solution : 7.5% Icodextrin
(Glucose Polymer)
Peritoneal access device
• Tenchoff catheter
• Straight bag system
• Y-set
• Double bag system
– Connect
– Drain
– Flush
– Fill
– Disconnect
PD Technique & PrescriptionPD Technique & Prescription
Automate PD
Dialysis related peritonitisDialysis related peritonitis
• Diagnosis (2 of 3)Diagnosis (2 of 3)
1. Clinical : Fever, Abdominal pain,
Cloudy dialysate
2. PDF cell diff/cell count : WBC ≥ 100
(PMN ≥ 50%), in dwell time for 4 hr
3. PDF Culture : Positive
Investigation
CBC
Elyte , BUN , Cr , alb
H/C
CXR
Film KUB
PDF fluid : cell diff , cell count , culture
gram stain (for Dx fungal infection)
Route of InfectionRoute of Infection
• Transluminal  Hx Touch contamination
• Periluminal  exit site infection, tunnel infection ?
• Transmural  diarrhea ? Constipation ?
• Transvaginal  leukorrhea , PID ?
• Hematogenous  other source of infection
DDx. In Cloudy DialysateDDx. In Cloudy Dialysate
1. Culture-positive infectious peritonitis
2. Culture-negative Infectious peritonitis
3. Chemical peritonitis
4. Eosinophilia of the effluent
5. Hemoperitoneum
6. Malignancy (rare)
7. Chylous effluent (rare)
8. First drainage after break in period
Abnormal PD SolutionAbnormal PD Solution
• Rule out 2nd
Peritonitis
– Acute appendicitis
– Ruptured viscus
– Diverticulitis
– Strangulated hernia
• สงสัยเมื่อ ??
– Hx : ปวดท้องก่อนนำ้ำยำขุ่น / ปวดท้องแต่
นำ้ำยำไม่ขุ่น
– P.E. : PR Exam, Localizing pain
– Mixed organisms
– Free air ???  CAPD < Automate PD
PD related peritonitisPD related peritonitis
• หลักการให้ Antibiotic
–Empiric antibiotics:
• Cover Gram+ve & Gram-ve organisms
• Center-specific selection of empiric therapy
• History of sensitivities of organisms causing
peritonitis
–Gram +ve : 1st
Cephalosporin
–Gram -ve : 3rd
Cephalosporin or
Aminoglycoside
PD related peritonitisPD related peritonitis
• Empiric regimen:Empiric regimen:
Cefazolin 1 gm i.p.
+
Cetazidime 1 gm.i.p
in PDF 2,000 ml ,dwell time ≥ 6 hours
• In Clinical Severe SepsisIn Clinical Severe Sepsis
Cefazolin + Cetazidime  i.p. and i.v. Loading dose
Then if clinical improve  only i.p. route
PD related peritonitisPD related peritonitis
Empirical antibioticEmpirical antibiotic
Clinical Assessment on day 3-5Clinical Assessment on day 3-5
Microbes Isolated from culture ,Adjust antibioticsMicrobes Isolated from culture ,Adjust antibiotics
Clinical improvement
& evaluate exit site and tunnel
Clinical improvement
& evaluate exit site and tunnel
No clinical improvement
Reculture and evaluate
No clinical improvement
Reculture and evaluate
No clinical improvement by
day 5 after appropriate
antibiotic
: off catheter
No clinical improvement by
day 5 after appropriate
antibiotic
: off catheter
Exit site or tunnel infection
Off catheter
Exit site or tunnel infection
Off catheter
clinical improvement
Continue antibiotics
clinical improvement
Continue antibiotics
Empirical antibioticEmpirical antibiotic
Clinical Assessment on day 3-5Clinical Assessment on day 3-5
Microbes Isolated from culture ,Adjust antibioticsMicrobes Isolated from culture ,Adjust antibiotics
Clinical improvement
& evaluate exit site and tunnel
Clinical improvement
& evaluate exit site and tunnel
No clinical improvement
Reculture and evaluate
No clinical improvement
Reculture and evaluate
No clinical improvement by
day 5 after appropriate
antibiotic
: off catheter
No clinical improvement by
day 5 after appropriate
antibiotic
: off catheter
Exit site or tunnel infection
Off catheter
Exit site or tunnel infection
Off catheter
clinical improvement
Continue antibiotics
clinical improvement
Continue antibiotics
< 4 weeks , different organism
< 4 weeks , same organism
> 4 weeks , same organism
Exit site
Twardowski Score
Perfect exit
Good exit
Equivocal exit
Acute infection
Chronic infection
Exit trauma
Equivocal exit site infections
purulent or bloody
drainage is only
present in the sinus
and cannot be
expressed outside.
Acute exit site infection
characterized by redness,
swelling and tenderness.
The erythema is more than
twice the diameter of the
catheter and there is
regression of the
epithelium in the sinus.
Chronic infection
ent both externally and in the sinus of the exit site in chronic infections. The exit is sometimes covered by a large, persistent crust or scab. There is usually no
Granulation tissue is
typically present
both externally and
in the sinus of the
exit site in chronic
infections.
Exit trauma
ESI Scoring System
0 point 1 point 2 points
Swelling 0 < 0.5 cm > 0.5 cm
Crust 0 < 0.5 cm > 0.5 cm
Redness 0 < 0.5 cm > 0.5 cm
Pain 0 Slight Severe
drainage 0 Serous Purulent
Score = or > 4 : ESI ; purulent drainage ESI
Score < 4 may or may not represent ESI
UF failure
1.Compliance (oral Na , drug) ?
2.Cardiovascular cause ?
3.Evaluate residual renal function (nephrotoxic
drug ) ?
4.Mechanic Failure ?
a. Obstruction ,Entrapment , Malposition
b. Hernia , leakage
5.Peritoneal Function ?
Evaluation
• Hx
– Cardiovascular disorder ?
– Lean body mass
– Salt and water
– Residual renal function (nephrotoxic agent ?)
• PE
– Exit site leakage
– Hernia pericatheter ,genital ,inguinal ,femoral area
– Edema : generalized , unilateral , localized , decrease
BS ,abdominal wall ,inguinal area , genitalia
Evaluation
•Malposition of catheter
•Pleural effusion
•Asymetrical Abdominal bulging
•Hernia
Fluid overload
PE & Hx
Rapid fill and drain , film KUB AP & lateral
พบสาเหตุ
Catheter malposition
Leakage
occlusion
ไม่พบสาเหตุ
PET
Drain volume
Drain volume ลดลง
UF ลดลง
D/P คงที่D/P ลดลง (low transport) D/P เพิ่ม (high transport)
Drain volume D/P ไม่เปลี่ยนแปลง
Decrease Residual renal Fn
Sclerosing peritonitis
Peritoneal fibrosis
adhesion
Increase lymphatic absorption
Aquaporin deficiency
Leakage
malposition
Recent peritonitis
(30-60 mindelta5)
Treatment
• Collect cause
• Diuretics
• 4.25%PDF <> 1.5%PDF
• Increase frequency (high transporter)
General Care
General Care

More Related Content

What's hot

ADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSISADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSIS
saihari17
 
How to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacyHow to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacy
Ahmed Mostafa Taha Borham
 
Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)
Mahmoud Eid
 
Evaluation of peritoneal membrane
Evaluation of peritoneal membraneEvaluation of peritoneal membrane
Evaluation of peritoneal membrane
Muhammad Mohsin Riaz
 
Peritoneal dialysis part1
Peritoneal dialysis part1Peritoneal dialysis part1
Peritoneal dialysis part1
FarragBahbah
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
Abdullah Ansari
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
MNDU net
 
Extracorporeal liver support therapies
Extracorporeal liver support therapies Extracorporeal liver support therapies
Extracorporeal liver support therapies
Ayman Seddik
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortaltyxinnirah
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
NephroTube - Dr.Gawad
 
Patient selection and training for peritoneal dialysis
Patient selection  and training for peritoneal dialysisPatient selection  and training for peritoneal dialysis
Patient selection and training for peritoneal dialysis
Ayman Seddik
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
FarragBahbah
 
Hd and hdf
Hd and hdfHd and hdf
Hd and hdf
Richard McCrory
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
Dr. Prem Mohan Jha
 
Dr tamer el said pd catheter insertion
Dr tamer el said   pd catheter insertionDr tamer el said   pd catheter insertion
Dr tamer el said pd catheter insertion
FarragBahbah
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
Dr. Nitish kumar
 
Renal anemia
Renal anemiaRenal anemia
Dr hesham elsayed hd adequacy and dose optimization
Dr hesham elsayed   hd adequacy and dose optimizationDr hesham elsayed   hd adequacy and dose optimization
Dr hesham elsayed hd adequacy and dose optimization
FarragBahbah
 
Dry Weight 2018
Dry Weight 2018Dry Weight 2018
Adequacy hd
Adequacy hdAdequacy hd
Adequacy hd
FarragBahbah
 

What's hot (20)

ADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSISADEQUACY OF HEMODIALYSIS
ADEQUACY OF HEMODIALYSIS
 
How to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacyHow to improve Peritoneal dialysis adequacy
How to improve Peritoneal dialysis adequacy
 
Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)Dialysis without anticoagulation (Heparin Free Dialysis)
Dialysis without anticoagulation (Heparin Free Dialysis)
 
Evaluation of peritoneal membrane
Evaluation of peritoneal membraneEvaluation of peritoneal membrane
Evaluation of peritoneal membrane
 
Peritoneal dialysis part1
Peritoneal dialysis part1Peritoneal dialysis part1
Peritoneal dialysis part1
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
Extracorporeal liver support therapies
Extracorporeal liver support therapies Extracorporeal liver support therapies
Extracorporeal liver support therapies
 
Capd peritonitis mortalty
Capd peritonitis mortaltyCapd peritonitis mortalty
Capd peritonitis mortalty
 
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. GawadHTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
HTN in Hemodialysis Patients - A Clinical Approach of Management - Dr. Gawad
 
Patient selection and training for peritoneal dialysis
Patient selection  and training for peritoneal dialysisPatient selection  and training for peritoneal dialysis
Patient selection and training for peritoneal dialysis
 
Intra dialytic hypotension ,,, prof Alaa Sabry
Intra dialytic hypotension ,,,  prof Alaa SabryIntra dialytic hypotension ,,,  prof Alaa Sabry
Intra dialytic hypotension ,,, prof Alaa Sabry
 
Hd and hdf
Hd and hdfHd and hdf
Hd and hdf
 
Dialysis prescription
Dialysis prescriptionDialysis prescription
Dialysis prescription
 
Dr tamer el said pd catheter insertion
Dr tamer el said   pd catheter insertionDr tamer el said   pd catheter insertion
Dr tamer el said pd catheter insertion
 
Renal replacement therapy
Renal replacement therapyRenal replacement therapy
Renal replacement therapy
 
Renal anemia
Renal anemiaRenal anemia
Renal anemia
 
Dr hesham elsayed hd adequacy and dose optimization
Dr hesham elsayed   hd adequacy and dose optimizationDr hesham elsayed   hd adequacy and dose optimization
Dr hesham elsayed hd adequacy and dose optimization
 
Dry Weight 2018
Dry Weight 2018Dry Weight 2018
Dry Weight 2018
 
Adequacy hd
Adequacy hdAdequacy hd
Adequacy hd
 

Similar to Overview of peritoneal dialysis

serous fluid Dr shweta [Autosaved].pptx
serous fluid Dr shweta [Autosaved].pptxserous fluid Dr shweta [Autosaved].pptx
serous fluid Dr shweta [Autosaved].pptx
sandeepkumarGarg4
 
Pleural Effusion By Akhtar Totakhail.pptx
Pleural Effusion By Akhtar Totakhail.pptxPleural Effusion By Akhtar Totakhail.pptx
Pleural Effusion By Akhtar Totakhail.pptx
DrAkhtarMohammadTota
 
hemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccvhemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccv
FarezScrubHats
 
Acute pancreatitis.pptx
Acute pancreatitis.pptxAcute pancreatitis.pptx
Acute pancreatitis.pptx
Pradeep Pande
 
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfPD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
Ayman Seddik
 
Timing of surgery in mild biliary pancreatitis
Timing of surgery in mild biliary pancreatitisTiming of surgery in mild biliary pancreatitis
Timing of surgery in mild biliary pancreatitis
Aravind TK
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
Ramadan Arafa
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
glyf26shai
 
PICU OSCE.pdf
PICU OSCE.pdfPICU OSCE.pdf
PICU OSCE.pdf
Pushpa Latha
 
Vpl 605 clinical pathology
Vpl 605  clinical pathology Vpl 605  clinical pathology
Vpl 605 clinical pathology
SOURABH BABU
 
SURGERY PRESENTATION Choledocholithiasis
SURGERY PRESENTATION CholedocholithiasisSURGERY PRESENTATION Choledocholithiasis
SURGERY PRESENTATION Choledocholithiasis
aparnaviswanshoba
 
SMACC: Parr on Trauma Performance: How good can you get?
SMACC: Parr on Trauma Performance: How good can you get?SMACC: Parr on Trauma Performance: How good can you get?
SMACC: Parr on Trauma Performance: How good can you get?
SMACC Conference
 
Benign Anorectal Conditions - Ghana.pptx
Benign Anorectal Conditions - Ghana.pptxBenign Anorectal Conditions - Ghana.pptx
Benign Anorectal Conditions - Ghana.pptx
kwartengprince250
 
TSW GR on HD for Poisoning 2015
TSW GR on HD for Poisoning 2015TSW GR on HD for Poisoning 2015
TSW GR on HD for Poisoning 2015
bcooper876
 
Clinical features,diagnosis and treatment of tuberculosis
Clinical features,diagnosis and treatment of tuberculosisClinical features,diagnosis and treatment of tuberculosis
Clinical features,diagnosis and treatment of tuberculosis
docpiash
 
Intestinal Obstruction presentation for students.ppt
Intestinal Obstruction presentation for students.pptIntestinal Obstruction presentation for students.ppt
Intestinal Obstruction presentation for students.ppt
drkenany
 
KIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKeturah Kiper
 
Clinical case discussions
Clinical case discussions Clinical case discussions
Clinical case discussions
Namrata Chhabra
 

Similar to Overview of peritoneal dialysis (20)

serous fluid Dr shweta [Autosaved].pptx
serous fluid Dr shweta [Autosaved].pptxserous fluid Dr shweta [Autosaved].pptx
serous fluid Dr shweta [Autosaved].pptx
 
Pleural Effusion By Akhtar Totakhail.pptx
Pleural Effusion By Akhtar Totakhail.pptxPleural Effusion By Akhtar Totakhail.pptx
Pleural Effusion By Akhtar Totakhail.pptx
 
hemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccvhemodialisys HFCRevCCCourseMcGill2000 ccv
hemodialisys HFCRevCCCourseMcGill2000 ccv
 
Sbp
SbpSbp
Sbp
 
Acute pancreatitis.pptx
Acute pancreatitis.pptxAcute pancreatitis.pptx
Acute pancreatitis.pptx
 
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdfPD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
PD THE ROAD LESS TRAVELLED Dr Ayman Seddik 2.pdf
 
Timing of surgery in mild biliary pancreatitis
Timing of surgery in mild biliary pancreatitisTiming of surgery in mild biliary pancreatitis
Timing of surgery in mild biliary pancreatitis
 
Septic shock; latest update
Septic shock; latest updateSeptic shock; latest update
Septic shock; latest update
 
Presentasi Eka Hospital
Presentasi Eka HospitalPresentasi Eka Hospital
Presentasi Eka Hospital
 
Lupus nephritis
Lupus nephritisLupus nephritis
Lupus nephritis
 
PICU OSCE.pdf
PICU OSCE.pdfPICU OSCE.pdf
PICU OSCE.pdf
 
Vpl 605 clinical pathology
Vpl 605  clinical pathology Vpl 605  clinical pathology
Vpl 605 clinical pathology
 
SURGERY PRESENTATION Choledocholithiasis
SURGERY PRESENTATION CholedocholithiasisSURGERY PRESENTATION Choledocholithiasis
SURGERY PRESENTATION Choledocholithiasis
 
SMACC: Parr on Trauma Performance: How good can you get?
SMACC: Parr on Trauma Performance: How good can you get?SMACC: Parr on Trauma Performance: How good can you get?
SMACC: Parr on Trauma Performance: How good can you get?
 
Benign Anorectal Conditions - Ghana.pptx
Benign Anorectal Conditions - Ghana.pptxBenign Anorectal Conditions - Ghana.pptx
Benign Anorectal Conditions - Ghana.pptx
 
TSW GR on HD for Poisoning 2015
TSW GR on HD for Poisoning 2015TSW GR on HD for Poisoning 2015
TSW GR on HD for Poisoning 2015
 
Clinical features,diagnosis and treatment of tuberculosis
Clinical features,diagnosis and treatment of tuberculosisClinical features,diagnosis and treatment of tuberculosis
Clinical features,diagnosis and treatment of tuberculosis
 
Intestinal Obstruction presentation for students.ppt
Intestinal Obstruction presentation for students.pptIntestinal Obstruction presentation for students.ppt
Intestinal Obstruction presentation for students.ppt
 
KIPER_SCTRP_Presentation
KIPER_SCTRP_PresentationKIPER_SCTRP_Presentation
KIPER_SCTRP_Presentation
 
Clinical case discussions
Clinical case discussions Clinical case discussions
Clinical case discussions
 

More from ปิติ นิยมศิริวนิช

Radial artery patency after transradial catheterization
Radial artery patency after transradial catheterizationRadial artery patency after transradial catheterization
Radial artery patency after transradial catheterization
ปิติ นิยมศิริวนิช
 
Dental management in patients receiving anticoagulation or antiplatelet tre...
Dental management  in patients receiving anticoagulation or antiplatelet  tre...Dental management  in patients receiving anticoagulation or antiplatelet  tre...
Dental management in patients receiving anticoagulation or antiplatelet tre...
ปิติ นิยมศิริวนิช
 
Septic shock
Septic shockSeptic shock
Metabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pdMetabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pd
ปิติ นิยมศิริวนิช
 
Financial Skills ทักษะทางการเงินเบื้องต้น
Financial  Skills ทักษะทางการเงินเบื้องต้นFinancial  Skills ทักษะทางการเงินเบื้องต้น
Financial Skills ทักษะทางการเงินเบื้องต้น
ปิติ นิยมศิริวนิช
 
Disorder Of The Eyes
Disorder Of The EyesDisorder Of The Eyes
Lenient Versus Strict Rate Control ?
Lenient Versus  Strict  Rate  Control ?Lenient Versus  Strict  Rate  Control ?
Lenient Versus Strict Rate Control ?
ปิติ นิยมศิริวนิช
 

More from ปิติ นิยมศิริวนิช (10)

Radial artery patency after transradial catheterization
Radial artery patency after transradial catheterizationRadial artery patency after transradial catheterization
Radial artery patency after transradial catheterization
 
Dental management in patients receiving anticoagulation or antiplatelet tre...
Dental management  in patients receiving anticoagulation or antiplatelet  tre...Dental management  in patients receiving anticoagulation or antiplatelet  tre...
Dental management in patients receiving anticoagulation or antiplatelet tre...
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Metabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pdMetabolic complications in patients ongoing pd
Metabolic complications in patients ongoing pd
 
PD prescription
PD prescriptionPD prescription
PD prescription
 
Financial Skills ทักษะทางการเงินเบื้องต้น
Financial  Skills ทักษะทางการเงินเบื้องต้นFinancial  Skills ทักษะทางการเงินเบื้องต้น
Financial Skills ทักษะทางการเงินเบื้องต้น
 
Disorder Of The Eyes
Disorder Of The EyesDisorder Of The Eyes
Disorder Of The Eyes
 
Pericardial Disease
Pericardial DiseasePericardial Disease
Pericardial Disease
 
High Versus Low Dosing Of Oral Colchicine
High  Versus  Low  Dosing Of  Oral  ColchicineHigh  Versus  Low  Dosing Of  Oral  Colchicine
High Versus Low Dosing Of Oral Colchicine
 
Lenient Versus Strict Rate Control ?
Lenient Versus  Strict  Rate  Control ?Lenient Versus  Strict  Rate  Control ?
Lenient Versus Strict Rate Control ?
 

Recently uploaded

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 

Overview of peritoneal dialysis

  • 1. Overview of Peritoneal DialysisOverview of Peritoneal Dialysis Piti Niyomsirivanich, MD. Cardiology Fellowship of Maharat Nakhon Ratchasima Hospital
  • 3. Anatomy & PhysiologyAnatomy & Physiology • 3 Pore Model
  • 4. •Ultra-small or transcellular pores (0.4-0.6 nm.) • Exist in small numbers and constitute 1-2 % of all pores •Transport water only (sieving) :aquaporin-1(water channel) Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005 Free water
  • 5. •Small pores (4.0-6.0 nm.) • Exist in large numbers and constitute 95% of all pores •transport small solutes and water: interendothelial cleft Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005 Small solute e.g. Na ,K , Cr
  • 6. •Large pores (20-24 nm) •Exist in small numbers and constitute < 3% of all pores •Transport macromolecules and anatomically large clefts between endothelial cells : convection Michael F. FlessnerAm J Physiol Renal Physiol 288: F433–F442, 2005 albumin
  • 8. • Ultrafiltration – Oncotic pressure gradient – Hydrostatic pressure gradient • Diffusion – The concentration gradiant – Effective peritoneal surface area – Intrinsic peritoneal membrane resistance – Molecular weight of the solute • Fluid Reabsorption – Occurs via the lymphatics  constant rate 1 ml/min
  • 9.
  • 10. Sodium concentration in dialysate as a function of dwell time t. Stachowska-Pietka J et al. Am J Physiol Renal Physiol 2012;302:F1331-F1341 ©2012 by American Physiological Society
  • 11. Intraperitoneal volume of dialysate as a function of dwell time t. Stachowska-Pietka J et al. Am J Physiol Renal Physiol 2012;302:F1331-F1341 ©2012 by American Physiological Society
  • 12. Peritoneal Equilibration TestPeritoneal Equilibration Test • PET : การทดสอบประสิทธิภาพของเยื่อบุช่อง ท้องในการยอมให้สารผ่าน โดยเปรียบ เทียบความเข้มข้นของสาร ณ เวลาหนึ่ง • Concept : การดึงของเสียการดึงของเสีย : Bun, Cr, uremic toxin, K, P, Na : สัดส่วนความเข้มข้นของสารนั้น ในนำ้ายาที่ ปล่อยออก : Dสารนั้น ต่อความเข้มข้นของสารนั้น ในเลือด : Pสาร นั้น
  • 13. Peritoneal Equilibration TestPeritoneal Equilibration Test > 0.81 < 0.5 ดูเรื่องการดึงนำ้า (UF) ดูเรื่องการแพร่ของ solute
  • 14. PET High Transporter Low Transporter Less UF More UF High Solute Transport Low Solute Transport
  • 15. PD Technique & PrescriptionPD Technique & Prescription
  • 16. Peritoneal Equilibration TestPeritoneal Equilibration Test PET Prescription High Transporter Short dwell time Increase cycle High Average NIPD/CAPD Low Average High dose CAPD/CCPD Low High dose CCPD+RRF Switch to HD without RRF
  • 17. PD SolutionPD Solution • PDF Conc. : 1.5 % , 2.5%, 4.25% Dextrose • Electrolyte – Na (132 mEq/L) / Mg (0.5) / Cl (96) – NaCl 538 mg/dL Sodium-lactate 448 mg/dL CaCl 25.7mg/dL MgCl 5.08 mg/dL – Lactate (40)  Bicarbonate • pH : 5.2 (4-6.5) • Osmole : 346 • New Solution : 7.5% Icodextrin (Glucose Polymer)
  • 18. Peritoneal access device • Tenchoff catheter
  • 19.
  • 20. • Straight bag system • Y-set • Double bag system – Connect – Drain – Flush – Fill – Disconnect
  • 21. PD Technique & PrescriptionPD Technique & Prescription
  • 23. Dialysis related peritonitisDialysis related peritonitis • Diagnosis (2 of 3)Diagnosis (2 of 3) 1. Clinical : Fever, Abdominal pain, Cloudy dialysate 2. PDF cell diff/cell count : WBC ≥ 100 (PMN ≥ 50%), in dwell time for 4 hr 3. PDF Culture : Positive
  • 24. Investigation CBC Elyte , BUN , Cr , alb H/C CXR Film KUB PDF fluid : cell diff , cell count , culture gram stain (for Dx fungal infection)
  • 25. Route of InfectionRoute of Infection • Transluminal  Hx Touch contamination • Periluminal  exit site infection, tunnel infection ? • Transmural  diarrhea ? Constipation ? • Transvaginal  leukorrhea , PID ? • Hematogenous  other source of infection
  • 26. DDx. In Cloudy DialysateDDx. In Cloudy Dialysate 1. Culture-positive infectious peritonitis 2. Culture-negative Infectious peritonitis 3. Chemical peritonitis 4. Eosinophilia of the effluent 5. Hemoperitoneum 6. Malignancy (rare) 7. Chylous effluent (rare) 8. First drainage after break in period
  • 28. • Rule out 2nd Peritonitis – Acute appendicitis – Ruptured viscus – Diverticulitis – Strangulated hernia • สงสัยเมื่อ ?? – Hx : ปวดท้องก่อนนำ้ำยำขุ่น / ปวดท้องแต่ นำ้ำยำไม่ขุ่น – P.E. : PR Exam, Localizing pain – Mixed organisms – Free air ???  CAPD < Automate PD PD related peritonitisPD related peritonitis
  • 29. • หลักการให้ Antibiotic –Empiric antibiotics: • Cover Gram+ve & Gram-ve organisms • Center-specific selection of empiric therapy • History of sensitivities of organisms causing peritonitis –Gram +ve : 1st Cephalosporin –Gram -ve : 3rd Cephalosporin or Aminoglycoside PD related peritonitisPD related peritonitis
  • 30. • Empiric regimen:Empiric regimen: Cefazolin 1 gm i.p. + Cetazidime 1 gm.i.p in PDF 2,000 ml ,dwell time ≥ 6 hours • In Clinical Severe SepsisIn Clinical Severe Sepsis Cefazolin + Cetazidime  i.p. and i.v. Loading dose Then if clinical improve  only i.p. route PD related peritonitisPD related peritonitis
  • 31.
  • 32. Empirical antibioticEmpirical antibiotic Clinical Assessment on day 3-5Clinical Assessment on day 3-5 Microbes Isolated from culture ,Adjust antibioticsMicrobes Isolated from culture ,Adjust antibiotics Clinical improvement & evaluate exit site and tunnel Clinical improvement & evaluate exit site and tunnel No clinical improvement Reculture and evaluate No clinical improvement Reculture and evaluate No clinical improvement by day 5 after appropriate antibiotic : off catheter No clinical improvement by day 5 after appropriate antibiotic : off catheter Exit site or tunnel infection Off catheter Exit site or tunnel infection Off catheter clinical improvement Continue antibiotics clinical improvement Continue antibiotics
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39. Empirical antibioticEmpirical antibiotic Clinical Assessment on day 3-5Clinical Assessment on day 3-5 Microbes Isolated from culture ,Adjust antibioticsMicrobes Isolated from culture ,Adjust antibiotics Clinical improvement & evaluate exit site and tunnel Clinical improvement & evaluate exit site and tunnel No clinical improvement Reculture and evaluate No clinical improvement Reculture and evaluate No clinical improvement by day 5 after appropriate antibiotic : off catheter No clinical improvement by day 5 after appropriate antibiotic : off catheter Exit site or tunnel infection Off catheter Exit site or tunnel infection Off catheter clinical improvement Continue antibiotics clinical improvement Continue antibiotics
  • 40. < 4 weeks , different organism < 4 weeks , same organism > 4 weeks , same organism
  • 41.
  • 42. Exit site Twardowski Score Perfect exit Good exit Equivocal exit Acute infection Chronic infection Exit trauma
  • 43. Equivocal exit site infections purulent or bloody drainage is only present in the sinus and cannot be expressed outside.
  • 44. Acute exit site infection characterized by redness, swelling and tenderness. The erythema is more than twice the diameter of the catheter and there is regression of the epithelium in the sinus.
  • 45. Chronic infection ent both externally and in the sinus of the exit site in chronic infections. The exit is sometimes covered by a large, persistent crust or scab. There is usually no Granulation tissue is typically present both externally and in the sinus of the exit site in chronic infections.
  • 47. ESI Scoring System 0 point 1 point 2 points Swelling 0 < 0.5 cm > 0.5 cm Crust 0 < 0.5 cm > 0.5 cm Redness 0 < 0.5 cm > 0.5 cm Pain 0 Slight Severe drainage 0 Serous Purulent Score = or > 4 : ESI ; purulent drainage ESI Score < 4 may or may not represent ESI
  • 48.
  • 49.
  • 50. UF failure 1.Compliance (oral Na , drug) ? 2.Cardiovascular cause ? 3.Evaluate residual renal function (nephrotoxic drug ) ? 4.Mechanic Failure ? a. Obstruction ,Entrapment , Malposition b. Hernia , leakage 5.Peritoneal Function ?
  • 51. Evaluation • Hx – Cardiovascular disorder ? – Lean body mass – Salt and water – Residual renal function (nephrotoxic agent ?) • PE – Exit site leakage – Hernia pericatheter ,genital ,inguinal ,femoral area – Edema : generalized , unilateral , localized , decrease BS ,abdominal wall ,inguinal area , genitalia
  • 52. Evaluation •Malposition of catheter •Pleural effusion •Asymetrical Abdominal bulging •Hernia
  • 53. Fluid overload PE & Hx Rapid fill and drain , film KUB AP & lateral พบสาเหตุ Catheter malposition Leakage occlusion ไม่พบสาเหตุ PET Drain volume Drain volume ลดลง UF ลดลง D/P คงที่D/P ลดลง (low transport) D/P เพิ่ม (high transport) Drain volume D/P ไม่เปลี่ยนแปลง Decrease Residual renal Fn Sclerosing peritonitis Peritoneal fibrosis adhesion Increase lymphatic absorption Aquaporin deficiency Leakage malposition Recent peritonitis (30-60 mindelta5)
  • 54. Treatment • Collect cause • Diuretics • 4.25%PDF <> 1.5%PDF • Increase frequency (high transporter)

Editor's Notes

  1. Ultra-small or transcellular pores (4-6 A) are water channels or aquaporin-1.  They are numerous and resemble the water channels present in red blood cells and renal proximal tubules.  They transport water only (sieving) and are present in the endothelial cells of the peritoneal capillaries. 
  2. Sodium concentration in dialysate as a function of dwell time t. Dashed lines, clinical data (means ± SD); solid lines, model results.
  3. Intraperitoneal volume of dialysate (left) and glucose concentration in dialysate (right) as a function of dwell time t. Dashed lines, clinical data (means ± SD); solid lines, model results.